Cargando…

CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas

BACKGROUND: Neuroblastomas are characterized by hemizygous 1p deletions, suggesting that a tumor suppressor gene resides in this region. We previously mapped the smallest region of consistent deletion to a 2-Mb region of 1p36.31 that encodes 23 genes. Based on mutation analysis, expression pattern,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Tomoyuki, Igarashi, Jun, Okawa, Erin R., Gotoh, Takahiro, Manne, Jayanthi, Kolla, Venkatadri, Kim, Jessica, Zhao, Huaqing, Pawel, Bruce R., London, Wendy B., Maris, John M., White, Peter S., Brodeur, Garrett M.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483574/ https://www.ncbi.nlm.nih.gov/pubmed/18577749 http://dx.doi.org/10.1093/jnci/djn176

Ejemplares similares

Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
por: Naraparaju, Koumudi, et al.
Publicado: (2016)

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma
por: Higashi, Mayumi, et al.
Publicado: (2015)

Identification of two contiguous minimally deleted regions on chromosome 1p36.31–p36.32 in oligodendroglial tumours
por: Dong, Z, et al.
Publicado: (2004)

A new autosomal recessive nonsyndromic hearing impairment locus DFNB96 on chromosome 1p36.31-p36.13
por: Ansar, Muhammad, et al.
Publicado: (2011)

Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti, Isabella, et al.
Publicado: (2020)

A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
por: Orienti, Isabella, et al.
Publicado: (2019)

Poloxamer‐linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high‐risk neuroblastoma with primary and acquired chemoresistance
por: Alferiev, Ivan S., et al.
Publicado: (2022)

Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models
por: Alferiev, Ivan S., et al.
Publicado: (2022)

CHD5 inhibits metastasis of neuroblastoma
por: Laut, Astrid K., et al.
Publicado: (2021)

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009)

Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
por: Garcia, Idoia, et al.
Publicado: (2010)

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
por: Yagyu, Shigeki, et al.
Publicado: (2016)

Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma
por: Martinez-Monleon, Angela, et al.
Publicado: (2023)

SF-36 predicts 13-year CHD incidence in a middle-aged Swedish general population
por: Nilsson, Evalill, et al.
Publicado: (2019)

CHD8 suppression impacts on histone H3 lysine 36 trimethylation and alters RNA alternative splicing
por: Kerschbamer, Emanuela, et al.
Publicado: (2022)

PHOX2B is a suppressor of neuroblastoma metastasis
por: Naftali, Osnat, et al.
Publicado: (2016)

Oral health status of CHD and non-CHD adults of Lahore, Pakistan
por: Bokhari, Syed Akhtar Hussain, et al.
Publicado: (2011)

Progress in CHD Prevention
por: Lewis, Barry
Publicado: (1983)

CHD1 and CHD2 are positive regulators of HIV-1 gene expression
por: Rodgers, Melissa J, et al.
Publicado: (2014)

The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities
por: Manning, Benjamin J., et al.
Publicado: (2017)

SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma
por: Lu, Wenmei, et al.
Publicado: (2020)

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
por: Schleiermacher, G, et al.
Publicado: (2012)

Synthesis of a bacteriophage MB78 late protein by novel ribosomal frameshifting()
por: Kolla, Venkatadri, et al.
Publicado: (2000)

Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8
por: Marie, Corentine, et al.
Publicado: (2018)

Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma
por: Lopez, Gonzalo, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on CHD care and emotional wellbeing
por: Cousino, Melissa K., et al.
Publicado: (2020)

Photosensitivity and CHD2 Variants
por: Sosa, Rebecca García, et al.
Publicado: (2015)

Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours
por: Carén, H, et al.
Publicado: (2007)

WANTED: Better neuroblastoma biomarkers and better stratification
por: London, Wendy B.
Publicado: (2022)

Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes
por: Ng, David, et al.
Publicado: (2008)

CHL1 gene acts as a tumor suppressor in human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2018)

Identification of α-N-catenin as a novel tumor suppressor in neuroblastoma
por: Qiao, Jingbo, et al.
Publicado: (2019)

Differential Expression and Sex Chromosome Association of CHD3/4 and CHD5 during Spermatogenesis
por: Bergs, Judith W., et al.
Publicado: (2014)

Expression of Hcy and blood lipid levels in serum of CHD patients and analysis of risk factors for CHD
por: Liu, Weijing, et al.
Publicado: (2019)

MicroRNA-211 Expression Promotes Colorectal Cancer Cell Growth In Vitro and In Vivo by Targeting Tumor Suppressor CHD5
por: Cai, Chunxiao, et al.
Publicado: (2012)

Identification of CASZ1 nuclear export signal (NES) reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma
por: Liu, Zhihui, et al.
Publicado: (2016)

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality
por: Hoffmeister, Helen, et al.
Publicado: (2017)

Common CHD8 Genomic Targets Contrast With Model-Specific Transcriptional Impacts of CHD8 Haploinsufficiency
por: Wade, A. Ayanna, et al.
Publicado: (2019)

Role of CD36 in Palmitic Acid Lipotoxicity in Neuro-2a Neuroblastoma Cells
por: Urso, C. J., et al.
Publicado: (2021)

Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_misc5iakvriqhkh2npt4u6q34s